Skip to content

ACADIA PHARMACEUTICALS INC

ACAD

CIK 0001070494

← back to feed
Revenue (TTM)
$1.06B
+11.9% YoY Q1 Apr 2026
Net Income (TTM)
$121.07M
+72.7% YoY Q1 Apr 2026
EPS Diluted (TTM)
$0.71
+69.1% YoY Q1 Apr 2026
Gross Margin
20.2%
Q1 Apr 2026
Operating Margin
7.8%
Q1 Apr 2026
Net Margin
11.5%
Q1 Apr 2026
Free Cash Flow (TTM)
$59.16M
Q1 Apr 2026
Cash
$282.21M
Q1 Apr 2026
Total Debt
$22K
Q1 Apr 2026
Shares Outstanding
171.24M sh
Q1 Apr 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings